Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects

NCT04531150 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic

Interventions

DRUG: INV-101
DRUG: Placebo

Sponsor

Inversago Pharma Inc.